Celgene To Pay $1B For A Big Piece of Juno and T Cell Therapies

June 30, 2015 | It seemed only a matter of time. One of biotech's most aggressive deal makers, Celgene has struck a wide-ranging, billion-dollar partnership with Juno Therapeutics. Xconomy